Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

SEER
Seer, Inc. Class A Common Stock
stock NASDAQ

At Close
Jul 2, 2026 3:59:55 PM EDT
1.61USD-1.227%(-0.02)871,694
1.60Bid   1.62Ask   0.02Spread
Pre-market
Jul 2, 2026 9:06:30 AM EDT
1.63USD0.000%(0.00)3,506
After-hours
Jul 2, 2026 4:22:30 PM EDT
1.62USD+0.621%(+0.01)2,889
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 10, 2022
02:58PM EST  Updated: Seer Announces Broad Commercial Release of the   GlobeNewswire Inc
09:00AM EST  Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind   GlobeNewswire Inc
08:00AM EST  Seer Announces Broad Commercial Release of the   GlobeNewswire Inc
Dec 29, 2021
06:51PM EST  Investigation Alert: Did You Lose Money on Your Stock? Johnson Fistel, LLP   PR Newswire
08:05AM EST  Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference.   GlobeNewswire Inc
Dec 27, 2021
09:00PM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Seer, Inc. (Seer or the Company) (NASDAQ: SEER) on behalf of Seer stockholders. Our investigation concerns whether Seer has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
Dec 23, 2021
12:11PM EST  Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP   PR Newswire
Dec 20, 2021
07:05AM EST  - Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity (PIPE) financing and from non-redemption agreements -   GlobeNewswire Inc
Dec 12, 2021
09:00PM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Seer, Inc. (Seer or the Company) (NASDAQ: SEER) on behalf of Seer stockholders. Our investigation concerns whether Seer has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
Dec 5, 2021
08:36AM EST  Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP   PR Newswire
Dec 3, 2021
12:24PM EST  EXCLUSIVE: Seer Bio CFO, David R. Horn Says Co Will Give 2022 Fiscal Year Guidance Early Next Year   Benzinga
12:22PM EST  EXCLUSIVE: Seer Bio CFO, David R. Horn Says 'We Feel Really Well About Our Cash Position, We Have Years Of Cash Positon'   Benzinga
12:19PM EST  EXCLUSIVE: Seer Bio CEO, Omid Farokhzad Says Co Is In The Second Phase Of Its Commercialization   Benzinga
12:17PM EST  EXCLUSIVE: Seer Bio CEO, Omid Farokhzad & CFO, David R. Horn Now Interviewing On Benzinga's Live YouTube TV   Benzinga
11:26AM EST  EXCLUSIVE: Seer Bio CEO, Omid Farokhzad & CFO, David R. Horn To Appear On Benzinga's Live YouTube TV At 12:15 p.m. ET On Friday   Benzinga
Dec 2, 2021
09:00PM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Seer, Inc. (Seer or the Company) (NASDAQ: SEER) on behalf of Seer stockholders. Our investigation concerns whether Seer has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
Nov 29, 2021
04:05PM EST  Seer Appoints Meeta Gulyani to its Board of Directors   GlobeNewswire Inc
Nov 27, 2021
05:00AM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Seer, Inc. (Seer or the Company) (NASDAQ: SEER) on behalf of Seer stockholders. Our investigation concerns whether Seer has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
Nov 22, 2021
08:05AM EST  Seer to Participate in the Piper Sandler Virtual Healthcare Conference   GlobeNewswire Inc
Nov 20, 2021
10:55AM EST  Investigation Alert: Did You Lose Money on Your Investment? Johnson Fistel, LLP   PR Newswire
Nov 9, 2021
06:12PM EST  Seer Q3 EPS $(0.30) Misses $(0.28) Estimate, Sales $2.15M Beat $1.23M Estimate   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Nov 8, 2021
04:05PM EST  Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors   GlobeNewswire Inc
Nov 4, 2021
10:36AM EDT  UPDATE: Short Seller Bear Cave Research Issues Report On Seer 'Problems at Seer'   Benzinga
Oct 12, 2021
04:05PM EDT  Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the third quarter 2021 after market close on Tuesday, November 9, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Oct 1, 2021
11:12AM EDT  How Bad Are Seer's Earnings? | Return On Capital Employed   Benzinga
Sep 2, 2021
04:05PM EDT  Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.   GlobeNewswire Inc
Aug 13, 2021
10:10AM EDT  Shares of Seer Inc. (SEER) are rising over 6% Friday morning, after the company a narrower-than-expected loss per share and upbeat revenue for the second quarter.   RTTNews
09:20AM EDT  Morgan Stanley Maintains Equal-Weight on Seer, Lowers Price Target to $50   Benzinga
Aug 12, 2021
04:52PM EDT  Seer Q2 EPS $(0.27) Beats $(0.28) Estimate, Sales $1.33M Beat $790.00K Estimate   Benzinga
04:01PM EDT  Seer Bio Partners with Enlight Medical to Commercialize the Proteograph Product Suite in China   Benzinga
04:01PM EDT  Seer Bio Partners with Enlight Medical to Commercialize the   GlobeNewswire Inc
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Jul 13, 2021
04:05PM EDT  Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the second quarter 2021 after market close on Thursday, August 12, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Jun 25, 2021
10:33AM EDT  Looking Into Seer's Return On Capital Employed   Benzinga
Jun 17, 2021
04:02PM EDT  Biodesix, Seer Highlight Presentation Of Webinar 'A New Era in Precision Medicine - Uncovering the Depth & Breadth of the Plasma Proteome with Novel Proteomic Technologies'   Benzinga
Jun 9, 2021
10:42AM EDT  Seer Insights: Return On Capital Employed   Benzinga
May 28, 2021
12:39PM EDT  Exclusive: Seer Bio CEO, Omid Farokhzad Now Interviewing On 'Benzinga's 'Power Hour' Show   Benzinga
09:55AM EDT  Exclusive: Seer Bio CEO, Omid Farokhzad To Appear On 'Benzinga's 'Power Hour' Show At 12:30 p.m. EDT   Benzinga
May 27, 2021
05:22PM EDT  Exclusive: Seer Bio CEO, Omid Farokhzad To Appear On 'Benzinga's 'Power Hour' Show At 12:30 p.m. EDT On Friday   Benzinga
May 24, 2021
02:23PM EDT  Exclusive: Seer Bio CEO, Omid Farokhzad To Appear On Benzinga's 'Power Hour' Show At 12:30 p.m. EDT On Tuesday   Benzinga
02:21PM EDT  Exclusive: Seer Bio CEO, Omid Farokhzad To Appear On Benzinga's 'Power Hour' Show At 12:30 p.m. EDT   Benzinga
May 12, 2021
08:58AM EDT  Morgan Stanley Maintains Equal-Weight on Seer, Lowers Price Target to $55   Benzinga
May 10, 2021
04:42PM EDT  Seer Q1 EPS $(0.27) Misses $(0.20) Estimate   Benzinga
04:05PM EDT  Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers   GlobeNewswire Inc
04:09AM EDT  Earnings Scheduled For May 10, 2021   Benzinga
May 4, 2021
04:05PM EDT  Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating virtually in the upcoming BofA Securities 2021 Healthcare Conference.   GlobeNewswire Inc
Apr 12, 2021
04:05PM EDT  Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 10, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Mar 30, 2021
07:52AM EDT  Morgan Stanley Maintains Equal-Weight on Seer, Lowers Price Target to $60   Benzinga
12:04AM EDT  Apple, Netflix, Peloton, Square, Roku, DraftKings - What Cathie Wood's Ark Bought And Sold On Monday   Benzinga
Mar 29, 2021
04:11PM EDT  Seer Q4 EPS $(0.54) Misses $(0.48) Estimate, Sales $336.00K Beat $100.00K Estimate   Benzinga
04:10PM EDT  Seer And SCIEX Announced That They Signed A Commercial Agreement To Offer End-To-end Ubbiased Proteomics Solutions   Benzinga
04:05PM EDT  Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the quarter and full year ended December31, 2020.   GlobeNewswire Inc
04:05PM EDT  Seer and SCIEX Sign Commercial Agreement to Offer End-to-End   GlobeNewswire Inc
04:16AM EDT  Earnings Scheduled For March 29, 2021   Benzinga
Mar 1, 2021
08:05AM EST  Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Monday, March 29, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Feb 24, 2021
04:05PM EST  Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating in the upcoming Cowen 41st Annual Healthcare Conference.   GlobeNewswire Inc
Feb 17, 2021
08:00AM EST  Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board   GlobeNewswire Inc
Feb 1, 2021
04:05PM EST  Seer Announces Closing of Public Offering of Common Stock   GlobeNewswire Inc
Jan 25, 2021
04:35PM EST  Seer Reports 3.5M Share Common Stock Offering   Benzinga
04:35PM EST  Seer Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Jan 11, 2021
05:19PM EST  CORRECTION: Maverick Capital Management Reports In 13D Filing A 10.4% Stake In Seer   Benzinga
05:18PM EST  Maverick Capital Management Reports In 13D Filing A 10.4% Stake In Seer   Benzinga
08:14AM EST  Seer Signs Commercial Agreement To 'Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics'   Benzinga
08:05AM EST  Seer Signs Commercial Agreement to Provide Complete End-to-End   GlobeNewswire Inc
08:01AM EST  Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics   Benzinga
08:00AM EST  Seer and Bruker Sign Commercial Agreement to Expand Market for   GlobeNewswire Inc
Jan 4, 2021
04:05PM EST  Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.   GlobeNewswire Inc
Dec 29, 2020
10:12AM EST  Benzinga's Top Upgrades, Downgrades For December 29, 2020   Benzinga
08:16AM EST  Morgan Stanley Initiates Coverage On Seer with Equal-Weight Rating, Announces Price Target of $65   Benzinga
06:36AM EST  JP Morgan Initiates Coverage On Seer with Overweight Rating, Announces Price Target of $75   Benzinga
06:34AM EST  Cowen & Co. Initiates Coverage On Seer with Outperform Rating   Benzinga
Dec 26, 2020
09:16AM EST  The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks   Benzinga
Dec 12, 2020
01:46PM EST  Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More   Benzinga
Dec 11, 2020
08:11AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street   Benzinga
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
Dec 8, 2020
05:40PM EST  Seer Announces Closing of Initial Public Offering and Full   GlobeNewswire Inc
Dec 4, 2020
10:37AM EST  Seer Shares Indicating $34.26 On 263K Shares   Benzinga
10:26AM EST  Seer Shares Indicating $37.05 On 229K Shares   Benzinga
10:05AM EST  IPOs For Today: Silverback Therapeutics, 17 Education & Technology, PropTech Investment Corporation II, Siglion Therapeutics, FinTech Acquisition Corp, Seer   Benzinga
10:00AM EST  Seer Shares Will Open For Quote At 10:10 a.m. EST, Expected To Open For Trade After 10:20 a.m. EST; IPO Priced At $19/Share   Benzinga
05:35AM EST  Seer Priced 9.2M Share IPO @$19/Share   Benzinga
12:14AM EST  Seer Announces Pricing Of IPO Of 9.21 Mln Shares Of Class A Common Stock At $19/Shr   RTTNews


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC